Harvard Bioscience CFO Jennifer Cote Resigns-April 2024-www.financetom.com

Harvard Bioscience CFO Jennifer Cote Resigns

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Harvard Bioscience CFO Jennifer Cote Resigns

Apr 10, 2025 2:56 PM

05:34 PM EDT, 04/10/2025 (MT Newswires) -- Harvard Bioscience ( HBIO ) said Chief Financial Officer Jennifer Cote resigned, effective around May 12.

Mark Frost, 52, was named interim CFO, the company said Thursday in a regulatory filing.

Frost served as a consultant to Harvard Bioscience ( HBIO ) since January and was previously the CFO of Fathom Digital Manufacturing (FATH).

Previous page： BofA to buy $9 bln residential mortgage loan from Canada's TD, source says Next page： AmEx says it identified 30 consumer accounts potentially tied to Iran's government

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

BofA to buy $9 bln residential mortgage loan from Canada's TD, source says

Feb 7, 2025

Feb 7 (Reuters) - Bank of America ( BAC ) has agreed to buy a $9 billion portfolio of residential mortgage loans from Canadian lender Toronto-Dominion Bank ( MLWIQXX ), a source familiar with the matter said on Friday. ...

AmEx says it identified 30 consumer accounts potentially tied to Iran's government

Feb 7, 2025

Feb 7 (Reuters) - U.S. credit card giant American Express ( AXP ) said on Friday it had identified approximately 30 consumer accounts last year that might have been tied to the government of Iran. ...

AbbVie Says FDA Approves Emblaveo Antibiotic to Treat Abdominal Infections

Feb 7, 2025

02:03 PM EST, 02/07/2025 (MT Newswires) -- AbbVie ( ABBV ) said Friday it received approval from the US Food and Drug Administration for its antibiotic Emblaveo for the treatment of adults with complicated intra-abdominal infections. The approval covers Emblaveo's use with metronidazole in patients who have limited or no alternative options to treat their infections, including those caused by...

Market Chatter: Magnite to Provide Programmatic Ad Sales Support to X

Feb 7, 2025

02:19 PM EST, 02/07/2025 (MT Newswires) -- Magnite ( MGNI ) is collaborating with Elon Musk's X to boost the social media platform's programmatic advertising sales, Business Insider reported Friday, citing Magnite's ( MGNI ) spokesperson. The partnership gives advertisers an option to add or remove X's inventory from their media buys, the spokesperson reportedly said. Neither Magnite ( MGNI...